SecBot SecBot
SECBOTREPLAY Home › Report › NVS

NVS · The Eighth Circuit affirmed denial of Novartis's preliminary injunction…

NOVARTIS AG · COURT-RULING filed Jun 30, 2026 at 20:00 ET

At the news

BEARISHIMPACT 5/10

COURT-RULING filed Jun 30, 2026 at 20:00 ET

The Eighth Circuit affirmed denial of Novartis's preliminary injunction against Missouri's S.B. 751, which prohibits drug manufacturers from restricting 340B drug deliveries to contract pharmacies. This ruling upholds a growing trend of state laws limiting manufacturers' ability to control distribution, increasing compliance costs and reducing profitability of the 340B program for Novartis.

  • Eighth Circuit upheld district court's denial of Novartis's preliminary injunction against Missouri S.B. 751.
  • S.B. 751 prohibits drug manufacturers from restricting delivery of 340B drugs to contract pharmacies of covered entities.
  • Court found Novartis unlikely to succeed on dormant Commerce Clause and preemption claims.
  • 22 states have enacted similar laws, creating a patchwork of regulatory requirements.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access